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Michael B. Freeman, MD, and Mitchell H. Goldman, MD, Knoxville, Tenn
Purpose: The purpose of this study was to design an experimental model of endotension and to investigate whether
attachment site failure without endoleak results in higher aneurysm sac pressure (ASP).
Methods: Infrarenal aortic aneurysms were created in canines with an elliptical knitted polyester patch. Pressure
transducers were inserted into the aneurysm. Group I (n  4) underwent endovascular stent graft exclusion of the
aneurysm. An attachment site failure was formed in group II (n 5) before aneurysm exclusion. ASP measurements were
obtained for 3 weeks, and the ratio of mean ASP to mean systemic blood pressure (ASP/BP) was calculated. Before
explant, norepinephrine was administered and ASPs were recorded at varying systemic pressures. Stent graft cuff
exclusion of the attachment site failure was performed in group II.
Results: Intraoperative arteriography and duplex ultrasonagraphy did not reveal an endoleak in either group. ASP/BP in
group I was 0.39  0.02 compared with 1.01  0.02 in group II (P < .001). Mean systemic pressure varied from 55 to
177 mm Hg after norepinephrine administration. Within this interval, ASP/BP was 0.51  0.10 in group I compared
with 0.91  0.10 in group II (P < .001). ASP/BP before cuff deployment in group II was 0.98  0.08 compared with
0.46  0.04 after cuff deployment (P < .001).
Conclusion: Systemic pressure is transmitted to the aneurysm sac through an attachment site failure, despite no endoleak,
resulting in endotension. Cuff exclusion of the attachment site failure decreases ASP. ASP may help determine the need
for future intervention after endovascular aneurysm repair. (J Vasc Surg 2002;36:814-7.)
Endovascular repair has significantly changed the ap-
proach to the treatment of patients with abdominal aortic
aneurysms (AAAs). There are, however, complications and
issues unique to this treatment method that may influence
the long-term durability of the procedure. One of these
issues is endotension, recently described and defined as
persistent or recurrent pressurization of the aneurysm sac
after endovascular repair.1
Transmission of pressure through thrombus or ather-
oma at the proximal attachment site is a possible mecha-
nism of endotension. It has been proposed that endoten-
sion may account for cases of aneurysm rupture in the
absence of endoleak and that aneurysms that enlarge or fail
to decrease in size may remain pressurized.1-5 Although the
concept of endotension seems logical, it has not yet been
shown experimentally.
The purpose of this study was to design an experimen-
tal model of endotension by creating an attachment site
failure without endoleak before stent graft exclusion of
AAA in canines. We tested the hypothesis that pressure
could be transmitted to the aneurysm sac through an
attachment site failure despite no endoleak.
MATERIALS AND METHODS
All animal procedures and care were performed in
accordance with an animal use protocol approved by the
University of Tennessee Animal Care and Use Committee
and complied with the “Principles of Laboratory Animal
Care” formulated by the National Society for Medical
Research and the “Guide for the Care and Use of Labora-
tory Animals” (NIH Publication No. 86-23, revised 1985).
Surgical procedures. Surgical and interventional pro-
cedures were performed on female mongrel dogs weighing
20 to 25 kg. The animals were divided into two groups.
Group I (n  4), the control group, underwent endovas-
cular stent graft exclusion after creation of an AAA. Group
II (n  5), the attachment site failure group, underwent
endovascular stent graft insertion after creation of an AAA
and an attachment site failure.
After orotracheal intubation and induction with so-
dium pentothal, the abdominal aorta and all branches were
isolated from the renal arteries to the aortic trifurcation.
Systemic heparin was given in a dose of 10 mg/kg body
weight, and the aorta was cross clamped. In group I, a 6
3–cm elliptical knitted polyester patch was sutured to a
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6-cm longitudinal arteriotomy to create an infrarenal AAA.
Before aneurysm formation in group II, a 3-cm segment of
a 10F Argyle shunt (Kendall, Mansfield, Mass) was secured
to the proximal aortic wall so that 1.5 cm of the shunt
extended into the aneurysm (Fig 1). The shunt had an
outer diameter of 3.3 mm and an inner diameter of 2.2
mm. The purpose of the shunt segment was to create an
attachment site failure once the endograft was deployed. All
aortic side branches in proximity to the AAA were ligated
and divided.
An implantable silicon strain-gauge pressure transducer
(P, 4.5; Konigsberg Instruments, Pasadena, Calif) was se-
cured to the luminal side of the knitted polyester compo-
nent of the aneurysm wall before stent graft deployment.
After aneurysm exclusion, a graft tunneler was used to pass
the cable and compensation module of the tranducer to an
area within the subcutaneous tissue between the scapulae of
the animals. External access was achieved with a skin button
appliance, allowing for daily measurements of aneurysm sac
pressure (ASP). The aneurysm was excluded in both groups
of animals with 8-cm  8-mm stent grafts (Talent;
Medtronic, Santa Rosa, Calif) inserted through the right
common iliac artery.
Assessment of abdominal aortic aneurysm exclu-
sion. Intraoperative arteriography was performed after
stent graft deployment to assess for the presence of en-
doleaks. Before explantation of the AAA and stent grafts,
color flow duplex ultrasonagraphy was used intraopera-
tively for endoleak assessment and AAA dimensions were
obtained. Arteriography also was performed at explanta-
tion.
Pressure measurements. Daily ASPs were obtained
for 3 weeks with connection of an analog-digital recorder
(Model 2700; Keithley Instruments, Cleveland, Ohio) to
the pressure transducer. In addition, daily forelimb sphyg-
momanometry was performed. The ratio of the mean ASP
to the mean systemic blood pressure (ASP/BP) was calcu-
lated to account for differences in BPs among the animals.
The ratio of the systolic pressure in the aneurysm sac to the
systemic systolic BP also was determined.
Correlation of aneurysm sac pressure with systemic
pressure. Three weeks after the initial surgical procedures,
a catheter was positioned in the abdominal aorta of the
animals proximal to the excluded AAA, via the right com-
mon iliac artery. The catheter was connected to a standard
pressure transducer for determination of systemic BP. Base-
line ASP and systemic pressures were obtained. To investi-
gate the relationship between ASP and increasing systemic
pressure, intravenous norepinephrine was administered and
ASP and systemic pressure were recorded.
Exclusion of attachment site failure. To test
whether exclusion of the attachment site failure decreased
ASP, a 5-cm stent graft cuff (Talent) was deployed (3 weeks
after the initial surgical procedure) to cover the attachment
site failure in group II. Arteriography was performed to
assess for the presence of endoleak. ASP and systemic
pressure were recorded at baseline and again after norepi-
nephrine administration to investigate whether exclusion of
the attachment site failure reduced the pressure within the
aneurysm sac.
Statistical analysis. ASP ratios are expressed as the
mean  standard error of the mean. SigmaStat version 2.0
for Windows (Jandel Scientific Software, San Rafael, Calif)
was used to perform t tests on the mean ASP ratios for the
two groups.
RESULTS
One dog in group 1 died in the recovery room of
respiratory arrest. Two dogs in group 2 were killed because
of hindlimb paralysis. All animals with patent stent grafts
were included in the analysis.
Assessment of endoleak. Intraoperative arteriogra-
phy performed at the time of initial AAA exclusion and at
explant did not reveal endoleak in any of the animals. In
addition, intraoperative color flow duplex ultrasonography
was performed at explant and confirmed the absence of
endoleak in both groups of animals.
Aneurysm size and characteristics. The mean aneu-
rysm diameter at the time of explant was 16  1.7 mm in
group I and 16.4  1.5 mm in group II. The mean aortic
diameter proximal to the aneurysm was 7.5  0.2 mm in
group I and 7.7  0.15 mm in group II. Organized
thrombus was seen within the aneurysm sac in both groups
and within the shunt in group II. The relative cross-sec-
tional area of the shunt to the patent stent graft lumen was
approximately 17%. No deformation of the shunt by the
proximal stent was found.
Aneurysm sac pressure measurements. During the
3-week study period, the mean ASP/BP in group I was
0.39  0.02 compared with 1.01  0.02 in group II (P 
.001). Similar findings were observed when the systolic
pressure ratios were calculated (Table). The ASP ratio
remained systemic over 3 weeks in group II (Fig 2).
Correlation of aneurysm sac pressure with manip-
ulation of systemic pressure. Before explantation, mean
ASP/BP before administration of norepinephrine was
Fig 1. Drawing of aneurysm model, with group I (control) and
group II (attachment site failure).
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0.44 0.08 in group I versus 0.98 0.08 in group II (P
.007). A three-fold increase in the mean systemic pressure
was achieved with norepinephrine (55 to 177 mm Hg), and
ASP/BP was determined over this range (Fig 3). ASP
increased in both groups of animals as systemic pressure
increased; however, the ASP/BP was maintained in the two
groups of animals over this interval: 0.51 0.10 for group
I compared with 0.91  0.10 for group II (P  .001).
Thus, for a given increase in systemic pressure, a signifi-
cantly greater increase was seen in ASP in the group with
the attachment site failure.
Endograft cuff repair of attachment site failure.
ASP/BP was calculated before and after cuff insertion in
the group II animals. Intraoperative arteriography and
color flow duplex ultrasonography did not reveal an en-
doleak or any blood flow into the aneurysm sac after cuff
deployment. ASP/BP before cuff deployment was 0.98 
0.08 compared with 0.47  0.04 after cuff deployment
(P  .001).
DISCUSSION
Experimental and clinical studies show that type I and
II endoleaks result in higher pressure within the aneurysm
sac.6-8 However, whether pressure exists in the aneurysm
sac in the absence of flow (endotension) is controversial and
has been a topic of heated debate. The presence of endo-
tension has largely been inferred from the observations of
aneurysm rupture or enlargement after endovascular AAA
repair in which no endoleak could be identified.
This study investigated endotension in an experimental
animal model. We hypothesized that pressure could be
transmitted to the aneurysm sac through thrombus. A
proximal attachment site failure was created with securing
an Argyle shunt to the canine aorta, with deployment of the
stent graft just below the proximal portion of the shunt.
Ligation and division of all outflow vessels resulted in
thrombosis of the aneurysm sac and thrombus formation
within the shunt. Thus, there was no flow into the aneu-
rysm sac through the shunt, which was confirmed with
intraoperative arteriography and duplex ultrasonagraphy.
The group of animals with an attachment site failure
showed mean and systolic ASP ratios that were basically
systemic (1.01 and 0.94, respectively). These ratios were
significantly higher than those of the group without the
attachment site failure (0.39 and 0.38, respectively). The
mechanism for the observed endotension in this experi-
mental model appears to be the transmission of aortic
pressure to the aneurysm sac through the attachment site
failure.
An additional finding from this study is that the mean
ASP ratio remained fairly constant with increasing systemic
pressure. This observation supports the hypothesis that
pressure transmission through the attachment site failure is
the mechanism for endotension in this model. It would also
suggest that BP control is especially advantageous in the
clinical situation when endotension is suspected.
We were also able to show that exclusion of the attach-
ment site failure with deploying a stent graft cuff proximal
to the shunt resulted in markedly reduced ASP ratios,
similar to the control group. This intervention is analogous
to deploying a proximal extender cuff for a type I endoleak
after AAA repair and may also represent a treatment option
for endotension.
Potential limitations exist in this study. The mean an-
eurysm diameter was 1.6 cm, twice the diameter of the
proximal canine aorta. This aneurysm model is smaller than
that encountered clinically. Whether the same forces and
physical properties exist within a larger aneurysm is not
known. Multiple factors likely contribute to the pressure
within the aneurysm sac. Systemic BP, aneurysm sac diam-
eter and volume, mechanical properties of the aneurysm
wall and stent graft device, and the size of the attachment
site failure or thrombus layer are important considerations.
What the short-term and long-term consequences are
of a pressurized aneurysm sac without an endoleak is un-
known. The law of LaPlace states that the wall tension in
the aneurysm sac is directly proportional to diameter and
Mean and systolic ASP/BP
ASP/BP (mean) ASP/BP (systolic)
I. Control 0.39  0.02 0.38  0.02
II. Attachment site failure 1.01  0.02 0.94  0.03
Fig 2. Mean ASP/BP recorded daily for 3-week study period.
Fig 3. Relationship between mean ASP/BP and increasing sys-
temic BP after administration of norepinephrine.
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pressure. The presence of endotension within the aneurysm
sac after endovacular AAA repair may signify treatment
failure and risk of aneurysm rupture. Rupture may not lead
to catastrophic hemorrhage if the proximal and distal stent
graft attachment sites remain secure. However, endoten-
sion may also be the result of a sealed type I endoleak, and
rupture could have disastrous consequences in that situa-
tion.1
Stent graft migration also has been implicated as a cause
of aneurysm rupture after endovascular AAA repair.2,3 In-
secure proximal fixation from an angulated neck or deploy-
ment too low in the neck may be responsible for subse-
quent graft migration in some of these cases.3 Another
possible explanation is that endotension may contribute to
the risk of stent graft migration or failure. The presence of
a pressurized aneurysm sac could lead to aneurysm growth
or dilation of the native aorta at the proximal or distal
attachment sites. This could result in graft migration, type
I endoleak, or rupture.
Clinical detection of endotension has been limited by
the inability to nonivasively measure ASP. Postoperative
surveillance after endovascular stent graft repair is primarily
performed with serial computed tomographic scans to mea-
sure aneurysm diameter or volume and to assess for the
presence of endoleak. However, endoleak (apart from type
I) appears to be a poor predictor for risk of aneurysm
rupture.2,3,9 Demonstration of endotension in patients
whose aneurysms enlarge or fail to shrink in size may be a
more reliable indicator of treatment failure. Given the
current state of technology, deployment of a small comput-
erized chip into the aneurysm or onto the body of the graft
at the time of endovascular repair that would allow serial
noninvasive measurements of ASP may be possible. As our
understanding of the consequences of endotension evolves,
ASP may help determine the need for future intervention
after endovascular AAA repair.
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